Efficacy and safety of adalimumab biosimilar GP2017 in a 24-month treatment period for plaque psoriasis: real-life experience from Emilia-Romagna centers, Italy
Lee, Marco May; Di Lernia, Vito; Peccerillo, Francesca; Bardazzi, Federico; Tabanelli, Michela; Ricci, Michela; Melandri, Davide; Corazza, Monica; Satolli, Francesca; Conti, Andrea
Share
Save